MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs
Condition: Epidermolysis Bullosa
Interventions: Drug: Thymoglobulin; Drug: Cyclophosphamide; Drug: Fludarabine; Radiation: Total Body Irradiation; Procedure: Bone marrow infusion; Drug: Tacrolimus; Drug: Mycophenolate Mofetil; Biological: Donor mesenchymal stem cell infusions
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting - verified February 2017
Interventions: Drug: Thymoglobulin; Drug: Cyclophosphamide; Drug: Fludarabine; Radiation: Total Body Irradiation; Procedure: Bone marrow infusion; Drug: Tacrolimus; Drug: Mycophenolate Mofetil; Biological: Donor mesenchymal stem cell infusions
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting - verified February 2017
News Type: